☆ 4.8 Letter

The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the sigma-1 receptor

MOLECULAR PSYCHIATRY (2013)

期刊

MOLECULAR PSYCHIATRY

卷 18, 期 1, 页码 12-14

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/mp.2012.3

关键词

类别

Biochemistry & Molecular Biology Neurosciences Psychiatry

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.8

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of a1 modulators

Kirsten T. Tolentino, Viktoriya Mashinson, Manish K. Sharma, Yashpal S. Chhonker, Daryl J. Murry, Corey R. Hopkins

Summary: The sigma 1 receptor, which is widely distributed in the nervous system, is implicated in various neurological disorders. A class of potent sigma 1 modulators has been identified, which can be studied in animal models.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Sigma-1 receptor and seizures

Edijs Vavers, Liga Zvejniece, Maija Dambrova

Summary: In the past decade, sigma-1 receptor (Sig1R) has emerged as a promising target for the treatment of seizure disorders. Clinical trials are currently underway to test Sig1R ligands as therapies for drug-resistant seizures and other related conditions. However, the precise molecular mechanism by which Sig1R modulates seizures and the balance between excitation and inhibition pathways remain unclear.

PHARMACOLOGICAL RESEARCH (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions

Liang Xu, Liao Y. Chen

Summary: This study characterizes the interactions between METH, sigma 1R, and DAT at a molecular level, finding that METH is more likely to act as an agonist for sigma 1R, with antagonists reducing its binding. Additionally, it demonstrates that sigma 1R can bind to dDAT through specific helix interactions, decreasing the binding affinity of METH to dDAT.

CHEMICAL BIOLOGY & DRUG DESIGN (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use

Lisa L. Wilson, Shainnel O. Eans, Insitar Ramadan-Siraj, Maria N. Modica, Giuseppe Romeo, Sebastiano Intagliata, Jay P. McLaughlin

Summary: SI 1/28 is an effective treatment for acute inflammatory pain and chronic neuropathy, without adverse effects at therapeutic doses. This supports the development of S1R antagonists as therapeutics for chronic pain.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

Igor D. Grachev, Philipp M. Meyer, Georg A. Becker, Marcus Bronzel, Doug Marsteller, Gina Pastino, Ole Voges, Laura Rabinovich, Helena Knebel, Franziska Zientek, Michael Rullmann, Bernhard Sattler, Marianne Patt, Thilo Gerhards, Maria Strauss, Andreas Kluge, Peter Brust, Juha-Matti Savola, Mark F. Gordon, Michal Geva, Swen Hesse, Henryk Barthel, Michael R. Hayden, Osama Sabri

Summary: Pridopidine demonstrates high affinity for the S1R in clinical trials, with near complete occupancy at a clinically relevant single dose of 90 mg. Minimal occupancy is seen at the D2/D3R, indicating pridopidine's selectivity as an S1R ligand. The dose-S1R occupancy relationship suggests cooperative binding of pridopidine to the S1R.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Chemistry, Medicinal

New tetrahydroisoquinoline-based D3R ligands with an o-xylenyl linker motif

Pierpaolo Cordone, Hari K. Namballa, Bryant Muniz, Rajat K. Pal, Emilio Gallicchio, Wayne W. Harding

Summary: In this study, the effect of rigidification of the n-butyl linker region of tetrahydroisoquinoline-containing D3R ligands by incorporating an o-xylenyl motif was investigated. Rigidification with an o-xylenyl linker group was found to decrease D3R affinity and impact selectivity versus D2R for compounds with a specific pharmacophore group, but high affinity D3R ligands with different primary pharmacophore groups were identified. The study also revealed that D3R selectivity versus sigma R-2 is influenced by the benzamide secondary pharmacophore group, particularly with 4-substituted benzamides, and identified specific compounds as high affinity D3R ligands.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H2R and D3R

Sabrina Biselli, Merlin Bresinsky, Katharina Tropmann, Lisa Forster, Claudia Honisch, Armin Buschauer, Gunther Bernhardt, Steffen Pockes

Summary: A series of novel H2R and D3R agonists with high affinities and selectivity have been synthesized in this study, showing promising application prospects in in vitro experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies

Parthena Martin, Thadd Reeder, Jo Sourbron, Peter A. M. de Witte, Arnold R. Gammaitoni, Bradley S. Galer

Summary: Recent evidence suggests that sigma-1 receptors may play a role in the pathogenesis of DEEs, with studies demonstrating that fenfluramine, a serotonin-releasing drug and positive modulator of sigma-1 receptors, can reduce seizures and improve everyday executive functions in patients with Dravet syndrome and Lennox-Gastaut syndrome. Opportunities for future research include developing appropriate models to evaluate sigma-1 receptors in these syndromic epileptic conditions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Clinical Neurology

Treatment of Stroke at a Delayed Timepoint with a Repurposed Drug Targeting Sigma 1 Receptors

Derek A. Schreihofer, Dhwanil Dalwadi, Seongcheol Kim, Daniel Metzger, Anthony Oppong-Gyebi, Paromita Das-Earl, John A. Schetz

Summary: In this study, it was found that oxeladin, a selective sigma 1 receptor agonist, could stimulate the release of BDNF and improve neurological function after stroke in rats. However, oxeladin did not reduce inflammation or increase cell proliferation, suggesting that its mechanisms of action may be different.

TRANSLATIONAL STROKE RESEARCH (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells

Judit Hodrea, Minh Ngoc Tran, Balazs Besztercei, Timea Medveczki, Attila J. Szabo, Laszlo Orfi, Illes Kovacs, Andrea Fekete

Summary: Primary open-angle glaucoma is a global issue without a definitive treatment. Increased intraocular pressure (IOP) is considered a primary risk factor, caused by fibrotic changes in the trabecular meshwork (TM). This study demonstrates that the sigma-1 receptor (S1R) agonist fluvoxamine (FLU) has anti-fibrotic effects in TM cells, reducing cell proliferation, migration, and fibrotic protein levels. The S1R protects against fibrosis by increasing nitric oxide production and facilitating extracellular matrix degradation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Review Genetics & Heredity

Role of Sigma-1 Receptor in Calcium Modulation: Possible Involvement in Cancer

Ilaria Pontisso, Laurent Combettes

Summary: Ca2+ signaling is crucial for cellular homeostasis and dysregulation can lead to various diseases, including cancer. The sigma-1 receptor (S1R) plays a key role in cancer progression by facilitating Ca2+ transfer at ER-mitochondrial contact sites, promoting cell survival through protective mechanisms.

GENES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Sigma-1 Receptor Modulation by Ligands Coordinates Cancer Cell Energy Metabolism

Furkan E. Oflaz, Zhanat Koshenov, Martin Hirtl, Rene Rost, Roland Malli, Wolfgang F. Graier

Summary: The study revealed that S1R plays an important role in cancer energy metabolism. Activation of S1R increases mitochondrial bioenergetics while reducing reliance on aerobic glycolysis in cancer cells. S1R antagonist, on the other hand, increases aerobic glycolysis in S1R expressing cancer cell line.

BIOMOLECULES (2022)

添加到收藏夹

Article Clinical Neurology

TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy

Aida Marcotti, Jorge Fernandez-Trillo, Alejandro Gonzalez, Marta Vizcaino-Escoto, Pablo Ros-Arlanzon, Luz Romero, Jose Miguel Vela, Ana Gomis, Felix Viana, Elvira de la Pena

Summary: The study reveals that sigma-1 receptor antagonists can regulate TRPA1 channels in nociceptors, reducing pain in a mouse model of oxaliplatin neuropathy. This finding suggests a novel strategy for the treatment of chemotherapy-induced peripheral neuropathy and offers insights for the development of new therapeutics for neuropathic pain.

BRAIN (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Intrathecal interleukin-1 beta decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain

Sheu-Ran Choi, Ho Jae Han, Alvin J. Beitz, Jang-Hern Lee

Summary: Administration of IL-1 beta during the early phase of nerve injury can reduce the expression of Sig-1R in spinal astrocytes, decrease pGluN1 expression, and suppress the development of mechanical allodynia and thermal hyperalgesia, producing an analgesic effect on neuropathic pain.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor

Pramisha Adhikari, Bing Xie, Ana Semeano, Alessandro Bonifazi, Francisco O. Battiti, Amy H. Newman, Hideaki Yano, Lei Shi

Summary: The study focuses on developing D3R selective agonists over D2R and identifies compound AB04-88 with significant D3R selectivity and G protein bias. The chirality of the primary pharmacophore is key in conferring improved D3R potency, selectivity, and G protein signaling bias.

BIOMOLECULES (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects

Marc Lopez-Cano, Joan Font, Ester Aso, Kristoffer Sahlholm, Gisela Cabre, Jesus Giraldo, Yves De Koninck, Jordi Hernando, Amadeu Llebaria, Victor Fernandez-Duenas, Francisco Ciruela

Summary: Photopharmacology offers a promising approach to improve the benefit/risk profiles of opioid-based drugs. This study successfully developed a morphine photo-derivative that can be activated by light, providing effective analgesia without the occurrence of tolerance or associated opioid-related side effects.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression

Antonio Flores-Burgess, Carmelo Millon, Belen Gago, Laura Garcia-Duran, Noelia Cantero-Garcia, Araceli Puigcerver, Jose Angel Narvaez, Kjell Fuxe, Luis Santin, Zaida Diaz-Cabiale

Summary: The study revealed that GAL(1-15) enhances the antidepressant effects of FLX in a depression animal model, potentially mediated through 5-HT1AR. This opens up the possibility of using a combination of GAL(1-15) and FLX as a novel treatment strategy for depression.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D2 Receptor

Richard agren, Kristoffer Sahlholm

Summary: SB269,652 is the first negative allosteric modulator of the dopamine D-2 receptor, but its mechanism of action is not fully understood. This study investigated the interaction between dopamine and SB269,652 and found that the inhibitory potency of SB269,652 is greatly increased after ligand pre-incubation. Mutagenesis experiments suggested that specific amino acids in the orthosteric binding site and the secondary binding pocket are involved in this effect. These findings expand our knowledge of how SB269,652 competes with dopamine at the D2R and could be important for the development of new D2R ligands.

BIOMEDICINES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Galanin and Neuropeptide Y Interaction Enhances Proliferation of Granule Precursor Cells and Expression of Neuroprotective Factors in the Rat Hippocampus with Consequent Augmented Spatial Memory

Marina Mirchandani-Duque, Miguel A. Barbancho, Alexander Lopez-Salas, Jose Erik Alvarez-Contino, Natalia Garcia-Casares, Kjell Fuxe, Dasiel O. Borroto-Escuela, Manuel Narvaez

Summary: This study evaluated the role of neuropeptide Y and galanin in hippocampal neurogenesis and found that they improve spatial memory by promoting cell proliferation and inducing neuroprotective factors. This finding provides a potential novel therapy for neurodegenerative cognitive-affecting diseases.

BIOMEDICINES (2022)

添加到收藏夹

Article Clinical Neurology

Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer's Disease APP/PS1 Mouse Model

Hector M. Estevez-Silva, German Cuesto, Ninovska Romero, Jose Miguel Brito-Armas, Abraham Acevedo-Arozena, Angel Acebes, Daniel J. Marcellino

Summary: Sigma-1 receptor agonists ACR16 and PRE-084 have been shown to promote the formation of new synapses and dendritic spines in vitro, while also exhibiting neuroprotective effects against oxidative stress and excitotoxicity. In an APP/PS1 mouse model, ACR16 improved spatial learning and memory deficits through activation of the PI3K/Akt pathway.

NEUROTHERAPEUTICS (2022)

添加到收藏夹

Article Neurosciences

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-383856

Marcus Saarinen, Ioannis Mantas, Ivana Flais, Richard Agren, Kristoffer Sahlholm, Mark J. Millan, Per Svenningsson

Summary: SEP-383856 (SEP-856) is a novel antipsychotic with a unique pattern of receptor interaction, showing agonist activity at TAAR1 and 5-HT1A receptors. Research indicates its potential advantages in treating schizophrenia and other psychotic disorders.

NEUROPSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Cell Biology

GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant-like effects involving BDNF actions

Jose Erik Alvarez-Contino, Estela Diaz-Sanchez, Marina Mirchandani-Duque, Jose Andres Sanchez-Perez, Miguel A. Barbancho, Alexander Lopez-Salas, Natalia Garcia-Casares, Kjell Fuxe, Dasiel O. Borroto-Escuela, Manuel Narvaez

Summary: This study found that intranasal infusion of GALR2 and Y1R agonists promotes neuroblast proliferation and induces the expression of the neurotrophic factor BDNF in the ventral hippocampus, resulting in antidepressant effects. These effects may be mediated by increased formation of Y1R-GALR2 heteroreceptor complexes. These findings may provide a new approach for the development of novel therapies for major depressive disorder.

JOURNAL OF CELLULAR PHYSIOLOGY (2023)

添加到收藏夹

Correction Neurosciences

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP- 363856 (vol 47, pg 2319, 2022)

Marcus Saarinen, Ioannis Mantas, Ivana Flais, Richard Agren, Kristoffer Sahlholm, Mark J. Millan, Per Svenningsson

NEUROPSYCHOPHARMACOLOGY (2023)

添加到收藏夹

Article Biology

Learning-related contraction of gray matter in rodent sensorimotor cortex is associated with adaptive myelination

Tomas Mediavilla, Ozgun Ozalay, Hector M. Estevez-Silva, Barbara Frias, Greger Oradd, Fahad R. Sultan, Claudio Brozzoli, Benjamin Garzon, Martin Lovden, Daniel J. Marcellino

Summary: Observations in rodents suggest that learning-dependent changes may involve increased dendritic spine density, alterations in astrocyte volume, and adaptations within intracortical myelin. Using a motor skill learning paradigm, this study found nonlinear increases in intracortical myelin during learning, supporting the hypothesis that myelin is a component of structural changes observed by voxel-based morphometry.

ELIFE (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2

Viktor Burstrom, Richard agren, Nibal Betari, Marta Valle-Leon, Emilio Garro-Martinez, Francisco Ciruela, Kristoffer Sahlholm

Summary: In this study, a novel nanoluciferase complementation assay was used to investigate the dopamine-induced recruitment of beta-arrestin2 (beta arr2) and G protein-coupled receptor kinase-2 (GRK2) to the D4 receptor. The desensitization of D4 receptor-evoked G protein-coupled inward rectifier potassium (GIRK) current responses was also studied. The results showed that coexpression of GRK2 enhanced the potency of dopamine to induce beta arr2 recruitment to the D4 receptor and accelerated the rate of desensitization of D4 receptor-evoked GIRK responses.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization

Marta Valle-Leon, Nil Casajuana-Martin, Claudia Llinas del Torrent, Josep Argerich, Laura Gomez-Acero, Kristoffer Sahlholm, Sergi Ferre, Leonardo Pardo, Francisco Ciruela

Summary: This study investigates the effect of three typical antipsychotic drugs on A2AR-D2R heteromer formation in mammalian cells using a NanoBiT assay. It was found that haloperidol and aripiprazole significantly increase the density of A2AR-D2R heteromers after 16 hours of exposure, while clozapine does not. Conversely, clozapine leads to a significant decrease in A2AR-D2R heteromerization after 2 hours of treatment, whereas haloperidol and aripiprazole do not. Computational binding models reveal distinct molecular signatures that explain these differential effects on heteromerization.

BIOMEDICINE & PHARMACOTHERAPY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

5HT1AR-FGFR1 Heteroreceptor Complexes Differently Modulate GIRK Currents in the Dorsal Hippocampus and the Dorsal Raphe Serotonin Nucleus of Control Rats and of a Genetic Rat Model of Depression

Patrizia Ambrogini, Davide Lattanzi, Marica Pagliarini, Michael Di Palma, Stefano Sartini, Riccardo Cuppini, Kjell Fuxe, Dasiel Oscar Borroto-Escuela

Summary: This study investigates the effects of 5HT1AR-FGFR1 complex activation on hippocampal pyramidal neurons and midbrain dorsal raphe serotonergic neurons using an electrophysiological approach. The results show that in normal rats, FGFR1 agonist-induced allosteric action counteracts the ability of 5HT1AR to open GIRK channels, leading to increased neuronal firing. However, in a depression rat model, the change in 5HT1AR caused by FGFR1 does not affect the GIRK channels, except in CA2 neurons. Therefore, the reduced inhibitory ability of FGFR1 on 5HT1AR-mediated GIRK channel opening may be associated with depression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Type I interferon shapes brain distribution and tropism of tick-borne flavivirus

Nunya Chotiwan, Ebba Rosendal, Stefanie M. A. Willekens, Erin Schexnaydre, Emma Nilsson, Richard Lindqvist, Max Hahn, Ionut Sebastian Mihai, Federico Morini, Jianguo Zhang, Gregory D. Ebel, Lars-Anders Carlson, Johan Henriksson, Ulf Ahlgren, Daniel Marcellino, Anna K. Overby

Summary: The authors use a multimodal imaging-snRNAseq transcriptomics strategy to study the distribution of a neurotropic tick-borne flavivirus in the brain. They find that absence of interferon signaling increases infection of resident microglia. Using multimodal imaging and single nuclei RNA-sequencing, they visualize viral pathogenesis and define molecular mechanisms. The study highlights the importance of understanding viral tropism and the role of immune response in neurotropic flavivirus infection.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

An E280K Missense Variant in KCND3/Kv4.3-Case Report and Functional Characterization

Richard Agren, Niels Geerdink, Han G. Brunner, Martin Paucar, Erik-Jan Kamsteeg, Kristoffer Sahlholm

Summary: A five-year-old girl with headache attacks and gait disturbances was found to have a new variant KCND3 c.838G>A, p.E280K in her father and sisters, but not in her mother and brother. KCND3 encodes voltage-gated potassium channel D3 (Kv4.3) and mutations have been associated with spinocerebellar ataxia type 19/22 (SCA19/22) and cardiac arrhythmias. The family members did not exhibit ataxia or parkinsonism, but both sisters showed mild developmental delay. Functional experiments showed that E280K affects channel activation and inactivation. Overall, E280K is associated with developmental delay but appears to be relatively benign.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Clinical Neurology

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics

Richard Agren, Nibal Betari, Marcus Saarinen, Hugo Zeberg, Per Svenningsson, Kristoffer Sahlholm

Summary: The study compared the efficacy of ulotaront and ralmitaront at TAAR1, 5-HT R-1A, and dopamine D 2. It was found that ralmitaront had lower efficacy at TAAR1 and had no activity at 5-HT R-1A and dopamine D 2. Compared to ulotaront, ralmitaront had lower efficacy and slower kinetics at TAAR1 and lacked efficacy at 5-HT R-1A.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2023)

添加到收藏夹

暂无数据

The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the sigma-1 receptor

期刊

出版社

NATURE PUBLISHING GROUP

关键词

类别

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文